The CCCC Stock Puzzle: Unraveling C4 Therapeutics Inc’s Fluctuating Performance

C4 Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $7.66 on 07/16/24, with the lowest value being $1.09 on 04/17/25.

52-week price history of CCCC Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. C4 Therapeutics Inc’s current trading price is -80.68% away from its 52-week high, while its distance from the 52-week low is 36.41%. The stock’s price range during this period has fluctuated between $1.09 and $7.66. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.12 million for the day, which was evidently higher than the average daily volume of 1.05 million over the last three months.

Financial Performance and Market Capitalization

C4 Therapeutics Inc (CCCC) has experienced a quarterly decline of -37.82% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 105.09M and boasts a workforce of 110 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.2587, with a change in price of -2.3800. Similarly, C4 Therapeutics Inc recorded 1,337,228 in trading volume during the last 100 days, posting a change of -61.66%.

CCCC Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CCCC stands at 0.33. Similarly, the long-term debt-to-equity ratio is also 0.30.

CCCC Stock Stochastic Average

The raw stochastic average for C4 Therapeutics Inc over the last 50 days is presently at 32.77%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 56.25%. Further, the company’s Stochastic %K and %D values for the last 20 days were 28.89% and 17.41%, respectively.

CCCC Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -58.89%. However, over the past six months, we’ve seen a stronger performance of -67.47%. The price of CCCC leaped by -14.94% over the last 30 days. And in the last five days, it has surged by 13.85%.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.